Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of serum testosterone by cyproterone acetate accompanied by an unexpected increase of calcitonin secretion

H Mulder, D Eland, W H Hackeng

    The Journal of Urology
    |August 1, 1987
    PubMed
    Summary

    Cyproterone acetate treatment for prostate cancer unexpectedly increased calcitonin secretion capacity, challenging previous links between sex hormones and calcitonin. This finding may offer additional therapeutic benefits, including bone sparing and pain relief.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology.

    Nature metabolism·2024
    Same author

    MicroRNA 29 modulates β-cell mitochondrial metabolism and insulin secretion via underlying miR-29-OXPHOS complex pathways.

    Acta physiologica (Oxford, England)·2024
    Same author

    Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2021
    Same author

    Mitochondrial clearance of calcium facilitated by MICU2 controls insulin secretion.

    Molecular metabolism·2021
    Same author

    [Guideline 'Organ donation following euthanasia"].

    Nederlands tijdschrift voor geneeskunde·2017
    Same author

    Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes.

    Nature communications·2017

    Area of Science:

    • Endocrinology
    • Oncology
    • Pharmacology

    Background:

    • Testosterone's role in prostate cancer is well-established.
    • Calcitonin secretion capacity's relationship with sex hormones requires further investigation.
    • Antiandrogenic agents are used in prostate cancer therapy.

    Purpose of the Study:

    • To investigate the effect of cyproterone acetate on calcitonin secretion capacity in prostate cancer patients.
    • To examine the interaction between testosterone levels and calcitonin secretion.
    • To evaluate potential benefits of observed effects.

    Main Methods:

    • Studied 9 patients with prostatic cancer.
    • Administered cyproterone acetate, an antiandrogenic agent.
    • Monitored serum testosterone and calcitonin secretion capacity.

    Related Experiment Videos

    Main Results:

    • Cyproterone acetate decreased serum testosterone as expected.
    • Calcitonin secretion capacity unexpectedly increased.
    • The positive correlation between sex hormones and calcitonin secretion may need revision.

    Conclusions:

    • Cyproterone acetate's effect on calcitonin secretion is complex and warrants further study.
    • The unexpected increase in calcitonin may offer therapeutic advantages, such as bone mass preservation and analgesia.
    • Findings challenge existing understanding of sex hormone and calcitonin interactions.